España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Agios Pharmaceuticals
AGIO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$34.19
-1.16
-3.28%
At close: -
$34.19
0.00
0.00%
After Hours: 1:00 PM EDT
Get Report
Comment
Agios Pharmaceuticals (AGIO) Forecast
News
Earnings
Agios Pharmaceuticals (AGIO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Agios Pharmaceuticals (NASDAQ:AGIO) Stock
Agios Pharmaceuticals Stock (NASDAQ: AGIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Cantor Fitzgerald Reiterates Overweight on Ag...
Benzinga Newsdesk
The European Commission Has Adopted A Positiv...
Benzinga Newsdesk
Monday, December 16, 2024
Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Tuesday, December 10, 2024
Analyst Ratings For Agios Pharmaceuticals
Benzinga Insights
RBC Capital Maintains Outperform on Agios Pha...
Benzinga Newsdesk
Monday, December 09, 2024
Scotiabank Maintains Sector Outperform on Agi...
Benzinga Newsdesk
Sunday, December 08, 2024
Agios Presented At ASH, Results From Phase 3 ...
Benzinga Newsdesk
Tuesday, November 05, 2024
Agios Pharmaceuticals Announced It Will Prese...
Benzinga Newsdesk
Friday, November 01, 2024
Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
RBC Capital Reiterates Outperform on Alnylam ...
Benzinga Newsdesk
Scotiabank Maintains Sector Outperform on Agi...
Benzinga Newsdesk
Thursday, October 31, 2024
Agios Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Agios Expects Cash And Equivalents, Together ...
Benzinga Newsdesk
Agios Pharmaceuticals Q3 Sales $8.96M Miss $9...
Benzinga Newsdesk
Wednesday, October 30, 2024
Earnings Preview: Agios Pharmaceuticals
Benzinga Insights
Wednesday, October 23, 2024
Agios Completes Enrollment In Phase 3 RISE UP...
Benzinga Newsdesk
Wednesday, October 16, 2024
Scotiabank Initiates Coverage On Agios Pharma...
Benzinga Newsdesk
Thursday, October 10, 2024
4 Analysts Have This To Say About Agios Pharmaceuticals
Benzinga Insights
Raymond James Reinstates Outperform on Agios ...
Benzinga Newsdesk
Friday, September 27, 2024
Agios Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Avi Kapoor
Micron To $150? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Leerink Partners Downgrades Agios Pharmaceuti...
Benzinga Newsdesk
Friday, September 20, 2024
Cantor Fitzgerald Reiterates Overweight on Ag...
Benzinga Newsdesk
Thursday, September 19, 2024
RBC Capital Reiterates Outperform on Agios Ph...
Benzinga Newsdesk
Wednesday, September 11, 2024
The FDA Granted Orphan Drug Designation To Ag...
Benzinga Newsdesk
Wednesday, August 07, 2024
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Tuesday, August 06, 2024
Agios To Receive $1.1B Milestone Payments Aft...
Benzinga Newsdesk
Friday, August 02, 2024
RBC Capital Maintains Outperform on Agios Pha...
Benzinga Newsdesk
Thursday, August 01, 2024
Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
Vandana Singh
Agios Pharmaceuticals Q2 2024 GAAP EPS $(1.69...
Benzinga Newsdesk
Agios Announces Results From Phase 3 ACTIVATE...
Benzinga Newsdesk
Monday, June 17, 2024
Expert Ratings For Agios Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ag...
Benzinga Newsdesk
Saturday, June 15, 2024
Agios Announced Earlier Results From Its Pha...
Benzinga Newsdesk
Friday, June 14, 2024
Agio Pharmaceuticals Announces Poster Titled ...
Benzinga Newsdesk
Thursday, June 13, 2024
JP Morgan Reinstates Neutral on Agios Pharmac...
Benzinga Newsdesk
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Sunday, June 09, 2024
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Lekha Gupta
Tuesday, June 04, 2024
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on Agios Phar...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Agios Pha...
Benzinga Newsdesk
Monday, June 03, 2024
Why Is Agios Pharmaceuticals Stock Trading Higher On Monday?
Vandana Singh
Agios Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Agios Pharmaceuticals Reports Phase 3 Results...
Benzinga Newsdesk
Tuesday, May 28, 2024
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
Vandana Singh
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch